4FZ-33623-48369 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-18
Dose 1 — Pfizer-BioNTech
2021-05-10
Registered in v-safe
2021-05-10
Dose 2 — Pfizer-BioNTech
2021-05-10
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-05-12
Survey response — days 1–6 daily, dose 2
MedDRA: Epistaxis, Menstrual disorder — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Nosebleed and abnormal period

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-12
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-11
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-08
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-15
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-05-12
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Contracted COVID

MedDRA releases: 2024-11 · check-in free text available
2022-05-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-05-13
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-18	Pfizer-BioNTech
2	2021-05-10	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-05-12	Successful 2022-04-15	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-05-12	Successful 2022-05-13	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-12

Systemic reaction (other): Nosebleed and abnormal period

Release 11 — 12 months, dose 2

2022-05-12

Symptoms: Contracted COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SRO	Epistaxis	✓	✓	✓
SRO	Menstrual disorder	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release